ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC34354-25mg |
|
— |
GSK2643943A
|
0 | C17H12FN3 | |
GC34354-10mg |
|
— |
GSK2643943A
|
0 | C17H12FN3 | |
GC34354-5mg |
|
— |
GSK2643943A
|
0 | C17H12FN3 | |
GC34354-10mM(1mLinDMSO) |
|
— |
GSK2643943A
|
0 | C17H12FN3 | |
GC34353-100mg |
|
— |
LMPTP INHIBITOR 1 hydrochloride
|
0 | C28H37ClN4O | |
GC34353-50mg |
|
— |
LMPTP INHIBITOR 1 hydrochloride
|
0 | C28H37ClN4O | |
GC34353-10mg |
|
— |
LMPTP INHIBITOR 1 hydrochloride
|
0 | C28H37ClN4O | |
GC34353-5mg |
|
— |
LMPTP INHIBITOR 1 hydrochloride
|
0 | C28H37ClN4O | |
GC34352-100mg |
|
— |
NMDAR antagonist 1
|
0 | C20H20BrN3O2 | |
GC34352-50mg |
|
— |
NMDAR antagonist 1
|
0 | C20H20BrN3O2 | |
GC34352-25mg |
|
— |
NMDAR antagonist 1
|
0 | C20H20BrN3O2 | |
GC34352-10mg |
|
— |
NMDAR antagonist 1
|
0 | C20H20BrN3O2 | |
GC34352-5mg |
|
— |
NMDAR antagonist 1
|
0 | C20H20BrN3O2 | |
GC34344-100mg |
|
— |
S-Gboxin
|
0 | C27H32F3IN2O2 | |
GC34344-50mg |
|
— |
S-Gboxin
|
0 | C27H32F3IN2O2 | |
GC34344-10mg |
|
— |
S-Gboxin
|
0 | C27H32F3IN2O2 | |
GC34344-5mg |
|
— |
S-Gboxin
|
0 | C27H32F3IN2O2 | |
GC34343-10mg |
|
— |
His-Pro hydrochloride
|
0 | C11H17ClN4O3 | |
GC34342-100mg |
|
2307249-33-6 |
BAY885
|
0 | C25H28F3N7O2 | |
GC34342-50mg |
|
2307249-33-6 |
BAY885
|
0 | C25H28F3N7O2 | |